Theorem Clinical Research

United States

Survey reveals knowledge gaps among Parkinson's patients and caregivers

Wednesday, September 10, 2014 03:04 PM

Information and specialized care can help patients become more engaged in their own treatment and in the Parkinson's disease (PD) community, according to a recent online survey of more than 1,500 PD patients, caregivers and physicians conducted by Harris Poll on behalf of the Michael J. Fox Foundation and AbbVie.

More... »


Report: clinical trials will continue to play a key role in oncology device market

Wednesday, September 10, 2014 03:03 PM

The U.S. interventional oncology device market will see strong growth, reaching a value of $760 million by 2023, according to Decision Resources Group. Rising cancer incidence rates, combined with the ineffectiveness of chemotherapy and demand for less invasive procedures, will support interventional oncology device uptake.

More... »


Livongo Health launched

Wednesday, September 10, 2014 03:00 PM

Livongo Health, a California-based consumer digital health company, has launched with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information and support from a chosen care team.

More... »

Oregon associations Oregon Bio and TAO collaborate

Monday, September 8, 2014 01:54 PM

Oregon Bioscience Association (Oregon Bio), a nonprofit member association based in Oregon, and the Technology Association of Oregon (TAO) are collaborating to cultivate Oregon's health information technologies, personal digital health products, bioinformatics and health analytics industries. Both organizations will coordinate support for companies, entrepreneurs, research institutes and care organizations to expand Oregon's life sciences and digital health economy.

More... »

AMRI's expands discovery biology offerings

Monday, September 8, 2014 01:52 PM

Albany Molecular Research (AMRI), a New York-based global CRO, has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018.

More... »

DrugDev named Best Place to Work by the Philadelphia Business Journal

Friday, September 5, 2014 10:12 AM

The Philadelphia Business Journal has named DrugDev one of its Best Places to Work in the Philadelphia region. The recognition continues the tradition established by CFS Clinical, a provider of global investigator payment, contracting and regulatory services, which had been named to the prestigious list each of the previous two years until it was acquired by DrugDev in October 2013.

More... »

Debiopharm Group's antibiotic Debio 1450 receives QIDP designation from the FDA

Friday, September 5, 2014 09:40 AM

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, has announced that the FDA has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

More... »

Johnson & Johnson to accelerate Ebola vaccine program in collaboration with NIH

Thursday, September 4, 2014 12:29 PM

Johnson & Johnson has committed to accelerate its Ebola vaccine program in collaboration with the NIH. J&J will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate to deliver immediate relief aid to address the current Ebola outbreak.

More... »

PRA Health Sciences expands in Pennsylvania

Wednesday, September 3, 2014 12:44 PM

PRA Health Sciences, a global CRO, is relocating Pennsylvania-based employees from its Horsham and Fort Washington locations into new office space in Blue Bell. The new office has opened and marks the first phase of PRA’s relocation plan. It soon will be PRA’s largest office worldwide.

More... »

Chimerix wins contract extension for development of smallpox treatment

Wednesday, September 3, 2014 12:39 PM

Chimerix, a Durham, N.C., biopharmaceutical company developing novel, oral antivirals, has been awarded a $17 million extension of its contract with the Biomedical Advanced Research and Development Authority (BARDA) for the development of its broad spectrum antiviral brincidofovir (BCV, CMX001) as a medical countermeasure to treat smallpox.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs